Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy

Jessica A. Cohen, Anna C. Mastroianni, Ruth Macklin

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Multipurpose prevention technologies (MPTs) designed to simultaneously prevent pregnancy and HIV could provide urgently needed tools to address unmet sexual and reproductive health needs of women worldwide. Late-stage clinical trials will be complex given the need to demonstrate efficacy for HIV and contraceptive indications simultaneously from a single product. Currently, HIV and pregnancy prevention trials have distinctive design features that will need to be reconciled in MPT trials. This article identifies several ethical issues uniquely associated with this research that will benefit from future deliberation and guidance to ensure that this globally important research can proceed efficiently and expeditiously.

Original languageEnglish (US)
Pages (from-to)221-224
Number of pages4
JournalInternational Journal of Gynecology and Obstetrics
Volume127
Issue number2
DOIs
StatePublished - Nov 1 2014

Keywords

  • Ethics
  • HIV prevention
  • Multipurpose prevention technologies
  • Pregnancy prevention

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy'. Together they form a unique fingerprint.

  • Cite this